ADVFN - Advanced Financial Network.
HOME» LSE » G » GSK Share Price » GSK Share News

Glaxosmithkline Share News

 Glaxosmithkline Share Price
GSK Share Price
 Glaxosmithkline Share Chart
GSK Share Chart
 Glaxosmithkline Share News
GSK Share News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Share Trades
GSK Share Trades
 Glaxosmithkline Share Message Board
GSK Share Message Board

GlaxoSmithKline to close Crawley factory in Sussex, 493 jobs to go

LONDON (Thomson Financial) - GlaxoSmithKline PLC. has announced hundreds of people will lose their jobs when it closes its factory in Sussex in 2011, the BBC reported citing a company spokesman. Some 493 people are expected to be affected when the multinational drugs company's Crawley site closes. The company blamed the closure on "declining volumes, regulatory delays and patent expiries". A spokesman said production at the site would continue until the products had been moved to alternative facilities. The spokesperson said: "GSK sincerely regrets the potential impact of this proposal in terms of job losses and will do all it can to help staff through this difficult period. "Implementation of this proposal will be subject to consultation with trade union and staff representatives at the Crawley site. This process will begin immediately." The factory currently produces medicines to treat Parkinson's disease, heart disease, HIV/AIDS, bacterial skin infections, depression, and hypertension. tf.TFN-Europe_newsdesk@thomsonreuters.com slm COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.

Share News for Glaxosmithkline (GSK)
DateTimeHeadline
30/03/201516:46:20GlaxoSmithKline PLC Director/PDMR Shareholding
30/03/201514:36:28Glaxo Reaches Agreement With UK Government For Meningitis B Vaccine
26/03/201512:43:10AstraZeneca, Glaxo Sign Up For 100,000 Genomes Project Consortium
26/03/201508:20:20Glaxo Gets Approval For Encruse Ellipta, Two Other Products In...
25/03/201512:00:07GlaxoSmithKline PLC Notice of AGM
23/03/201517:52:00When school is out, science is in! GSK Science in the Summer⢠g...
20/03/201507:00:11GlaxoSmithKline PLC US FDA Advisory Committee on BREO ELLIPTA
20/03/201506:24:27FDA Panel Recommends Approval Of GSK Asthma Drug For Adults
19/03/201514:26:48GlaxoSmithKline PLC Director Declaration
17/03/201511:43:09GSK Starts Phase 3 Program to Evaluate Retosiban For Preterm...
17/03/201511:34:28Glaxo Starts Phase III Programme For Retosiban In Premature Births
17/03/201508:59:04GlaxoSmithKline to Invest $25 Million in New Dementia Research...
16/03/201515:23:33GlaxoSmithKline PLC Director/PDMR Shareholding
13/03/201508:07:25GSK Raises $854 Million from Aspen Share Sale
13/03/201507:12:58GSK Raises $854 Million From Aspen Pharmacare Share Sale
13/03/201507:00:35GlaxoSmithKline PLC GSK completes partial sale of Aspen
13/03/201506:31:39PRESS: J&J Sues Glaxo Over False Advertising Claims - Reuters
12/03/201520:33:30LONDON MARKETS: FTSE 100 Rises As Drug Makers, SABMiller Advance
12/03/201520:33:14GSK Plans Partial Stake Sale in Aspen Pharmacare
12/03/201520:32:28GSK Plans to Sell About Half Its 12.4% Stake in Aspen Pharmacare...

Glaxosmithkline Plc and other London Stock Exchange share prices are delayed by at least 20 minutes.
All other share price data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad